{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:34:53Z","timestamp":1773300893242,"version":"3.50.1"},"reference-count":26,"publisher":"American Diabetes Association","issue":"1","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"abstract":"<jats:p>OBJECTIVE\u2014Wound healing is known to require a well-organized balance of numerous factors, e.g., cytokines, matrix metalloproteinases (MMPs), and their inhibitors, as well as direct cell-cell communication (connexins). Disruption of this balance may lead to the formation of chronic wounds such as diabetic foot ulcers. The transplantation of autologous keratinocytes is a promising therapy for diabetic foot ulcers; however, little is known about their characteristics on a molecular level. Therefore, we intended to characterize transplanted keratinocytes from diabetic and nondiabetic origin before and after transplantation.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014We isolated human keratinocytes from diabetic and nondiabetic origins and transplanted them into an ex vivo wound healing model. To characterize the keratinocytes, we investigated mRNA expression of MMP-1, MMP-2, and MMP-9; tissue inhibitor of MMP (TIMP)-1 and TIMP-2; interleukin (IL)-1\u03b2, tumor necrosis factor (TNF)-\u03b1; Cx26 (connexin 26) and Cx43; and, for connexins, immunolocalization.<\/jats:p>\n               <jats:p>RESULTS\u2014We found no significantly increased expression of the molecules investigated in cultured keratinocytes from diabetic compared with nondiabetic origin, even though there were significant differences for MMP-2, IL-1\u03b2, and TNF-\u03b1 in skin biopsies. Expression of IL-1\u03b2 was significantly lower in keratinocytes from diabetic origin. In the course of wound healing, differences in the dynamics of expression of MMP-1, IL-1\u03b2, and Cx43 were observed.<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014Our results suggest that keratinocytes from diabetic origin are as capable for transplantation into chronic wounds as keratinocytes from healthy origin at the starting point of therapy. However, differences in expression dynamics later on might reflect the systemic influence of diabetes resulting in a memory of the transplanted keratinocytes.<\/jats:p>","DOI":"10.2337\/dc07-1304","type":"journal-article","created":{"date-parts":[[2007,12,28]],"date-time":"2007-12-28T16:54:25Z","timestamp":1198860865000},"page":"114-120","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":68,"title":["Expression of Matrix Metalloproteinases, Cytokines, and Connexins in Diabetic and Nondiabetic Human Keratinocytes Before and After Transplantation Into an Ex Vivo Wound-Healing Model"],"prefix":"10.2337","volume":"31","author":[{"given":"Johanna M.","family":"Brandner","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venerology, University Hospital Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffi","family":"Zacheja","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Otto-von-Guericke University Hospital, Magdeburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Houdek","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venerology, University Hospital Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Moll","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venerology, University Hospital Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Lobmann","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Otto-von-Guericke University Hospital, Magdeburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","reference":[{"key":"2022031218504648100_R1","doi-asserted-by":"crossref","unstructured":"Lobmann R, Mu\u0308ller E, Kersken J, Bergmann K, Brunk-Loch S, Groene C, Lindloh C, Mertes B, Spraul M: The diabetic foot in Germany: analysis of quality in specialised diabetic wound care centers. TDFJ\u200810: 68\u201372, 2007","DOI":"10.1055\/s-2007-972294"},{"key":"2022031218504648100_R2","doi-asserted-by":"crossref","unstructured":"Mast BA, Schultz GS: Interactions of cytokines, growth factors and proteases in acute and chronic wound. Wound Repair Regen\u20084:411\u2013420, 1996","DOI":"10.1046\/j.1524-475X.1996.40404.x"},{"key":"2022031218504648100_R3","doi-asserted-by":"crossref","unstructured":"Lobmann R, Ambrosch A, Schultz GS, Waldmann K, Schiweck S, Lehnert H: Expression of matrixmetalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia\u200845:1011\u20131016, 2002","DOI":"10.1007\/s00125-002-0868-8"},{"key":"2022031218504648100_R4","doi-asserted-by":"crossref","unstructured":"Bullen EC, Longaker MT, Updike DL, Benton R, Ladin D, Hou Z, Howard EW: Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol\u2008104:236\u2013240, 1995","DOI":"10.1111\/1523-1747.ep12612786"},{"key":"2022031218504648100_R5","doi-asserted-by":"crossref","unstructured":"Marionnet AV, Chardonnet Y, Viac J, Schmitt D: Differences in responses of interleukin-1 and tumor necrosis factor alpha production and secretion to cyclosporin-A and ultraviolet B-irradiation by normal and transformed keratinocyte cultures. Exp Dermatol\u20086:22\u201328, 1997","DOI":"10.1111\/j.1600-0625.1997.tb00141.x"},{"key":"2022031218504648100_R6","doi-asserted-by":"crossref","unstructured":"Ito A, Sato T, Iga T, Mori Y: Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts. FEBS Lett\u2008269:93\u201395, 1990","DOI":"10.1016\/0014-5793(90)81127-A"},{"key":"2022031218504648100_R7","doi-asserted-by":"crossref","unstructured":"Lobmann R, Schultz G, Lehnert H: Molecular basis of wound healing in the diabetic foot syndrome. Diabetes Care\u200828:461\u2013471, 2005","DOI":"10.2337\/diacare.28.2.461"},{"key":"2022031218504648100_R8","doi-asserted-by":"crossref","unstructured":"Coutinho P, Qiu C, Frank S, Tamber K, Becker D: Dynamic changes in connexin expression correlate with key events in the wound healing process. Cell Biol Int\u200827:525\u2013541, 2003","DOI":"10.1016\/S1065-6995(03)00077-5"},{"key":"2022031218504648100_R9","doi-asserted-by":"crossref","unstructured":"Goliger JA, Paul DL: Wounding alters epidermal connexin expression and gap junction-mediated intercellular communication. Mol Biol Cell\u20086:1491\u20131501, 1995","DOI":"10.1091\/mbc.6.11.1491"},{"key":"2022031218504648100_R10","doi-asserted-by":"crossref","unstructured":"Brandner JM, Houdek P, Husing B, Kaiser C, Moll I: Connexins 26, 30, and 43: differences among spontaneous, chronic, and accelerated human wound healing. J Invest Dermatol\u2008122:1310\u20131320, 2004","DOI":"10.1111\/j.0022-202X.2004.22529.x"},{"key":"2022031218504648100_R11","doi-asserted-by":"crossref","unstructured":"Kretz M, Euwens C, Hombach S, Eckardt D, Teubner B, Traub O, Willecke K, Ott T: Altered connexin expression and wound healing in the epidermis of connexin-deficient mice. J Cell Sci\u2008116:3343\u20133452, 2003","DOI":"10.1242\/jcs.00638"},{"key":"2022031218504648100_R12","doi-asserted-by":"crossref","unstructured":"Qiu C, Coutinho P, Frank S, Franke S, Law L-Y, Martin P, Green CR, Becker DL: Targeting connexin 43 expression accelerates the rate of wound repair. Curr Biol\u200813:1697\u20131703, 2003","DOI":"10.1016\/j.cub.2003.09.007"},{"key":"2022031218504648100_R13","doi-asserted-by":"crossref","unstructured":"Mori R, Power KT, Wang CM, Martin P, Becker DL: Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration. J Cell Sci\u2008119:5193\u20135203, 2006","DOI":"10.1242\/jcs.03320"},{"key":"2022031218504648100_R14","doi-asserted-by":"crossref","unstructured":"Moustafa M, Simpson C, Glover M, Dawson RA, Tesfaye S, Creagh FM, Haddow D, Short R, Heller S, MacNeil S: A new autologous keratinocyte dressing treatment for non-healing diabetic neuropathic foot ulcers. Diabet Med\u200821:786\u2013789, 2004","DOI":"10.1111\/j.1464-5491.2004.01166.x"},{"key":"2022031218504648100_R15","unstructured":"Brem H, Young J, Tomic-Canic M, Isaacs C, Ehrlich HP: Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers. Surg Technol Int\u200811:23\u201331, 2003"},{"key":"2022031218504648100_R16","doi-asserted-by":"crossref","unstructured":"Limat A, French LE, Blal L, Saurat JH, Hunziker T, Salomon D: Organotypic cultures of autologous hair follicle keratinocytes for the treatment of recurrent leg ulcers. J Am Acad Dermatol\u200848:207\u2013214, 2003","DOI":"10.1067\/mjd.2003.69"},{"key":"2022031218504648100_R17","doi-asserted-by":"crossref","unstructured":"Myers S, Navsaria H, Sanders R, Green C, Leigh I: Transplantation of keratinocytes in the treatment of wounds. Am J Surg\u2008170:75\u201383, 1995","DOI":"10.1016\/S0002-9610(99)80258-X"},{"key":"2022031218504648100_R18","doi-asserted-by":"crossref","unstructured":"Acikgoz G, Devrim I, Ozdamar S: Comparison of keratinocyte proliferation in diabetic and non-diabetic inflamed gingiva. J Periodontol\u200875:989\u2013994, 2004","DOI":"10.1902\/jop.2004.75.7.989"},{"key":"2022031218504648100_R19","doi-asserted-by":"crossref","unstructured":"Blakytny R, Jude EB, Martin Gibson J, Boulton AJ, Ferguson MW: Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J Pathol\u2008190:589\u2013594, 2000","DOI":"10.1002\/(SICI)1096-9896(200004)190:5<589::AID-PATH553>3.0.CO;2-T"},{"key":"2022031218504648100_R20","doi-asserted-by":"crossref","unstructured":"Terenghi G, Mann D, Kopelman PG, Anand P: trkA and trkC expression is increased in human diabetic skin. Neurosci Lett\u2008228:33\u201336, 1997","DOI":"10.1016\/S0304-3940(97)00350-9"},{"key":"2022031218504648100_R21","unstructured":"Brandner JM, Houdek P, Quitschau T, Siemann-Harms U, Ohnemus U, Willhardt I, Moll I: An ex-vivo model to evaluate dressings & drugs for wound healing. example: influence of lucilia sericata extracts on wound healing progress. EWMA J\u20086:11\u201315, 2006"},{"key":"2022031218504648100_R22","doi-asserted-by":"crossref","unstructured":"Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G: Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen\u20087:442\u2013452, 1999","DOI":"10.1046\/j.1524-475X.1999.00442.x"},{"key":"2022031218504648100_R23","doi-asserted-by":"crossref","unstructured":"Armstrong DG, Jude EB: The role of matrix metalloproteinases in wound healing. J Am Podiatr Med Assoc\u200892:12\u201318, 2002","DOI":"10.7547\/87507315-92-1-12"},{"key":"2022031218504648100_R24","doi-asserted-by":"crossref","unstructured":"Saarialho-Kee UK: Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers. Arch Dermatol Res\u2008290 (Suppl.):S47\u2013S54, 1998","DOI":"10.1007\/PL00007453"},{"key":"2022031218504648100_R25","doi-asserted-by":"crossref","unstructured":"Wall SJ, Sampson MJ, Levell N, Murphy G: Elevated matrix metalloproteinase-2 and -3 production from human diabetic dermal fibroblasts. Br J Dermatol\u2008149:13\u201316, 2003","DOI":"10.1046\/j.1365-2133.2003.05262.x"},{"key":"2022031218504648100_R26","doi-asserted-by":"crossref","unstructured":"Trengove NJ, Bielefeldt-Ohmann H, Stacey MC: Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen\u20088:13\u201325, 2000","DOI":"10.1046\/j.1524-475x.2000.00013.x"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/31\/1\/114\/598270\/zdc00108000114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/31\/1\/114\/598270\/zdc00108000114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T19:59:10Z","timestamp":1647115150000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/31\/1\/114\/27897\/Expression-of-Matrix-Metalloproteinases-Cytokines"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc07-1304","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,1]]}}}